Back
Biomarin Pharmaceutical Stock Price Chart
This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Buy
56
BMRN
Biomarin Pharmaceutical
Last Price:
$57.42
Seasonality Move:
0.95%
7 Day Trial
ALL ACCESS PASS
$
7
The Future of Housing Is Being Built Now
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.98 | Sell |
| 20-day SMA: | 60.55 | Sell |
| 50-day SMA: | 63.45 | Sell |
| 200-day SMA: | 69.32 | Sell |
| 8-day EMA: | 59.07 | Sell |
| 20-day EMA: | 60.08 | Sell |
| 50-day EMA: | 62.26 | Sell |
| 200-day EMA: | 68.85 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.17 | Sell |
| Relative Strength Index (14 RSI): | 39.57 | Sell |
| Chaikin Money Flow: | -400087 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.78 - 62.42) | Sell |
| Bollinger Bands (100): | (60.17 - 69.27) | Sell |
Biomarin Pharmaceutical Technical Analysis
| May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
-
Biomarin Pharmaceutical share price is 58.01 while BMRN 8-day simple moving average is 58.98, which is a Sell signal.
-
The stock price of BMRN is 58.01 while Biomarin Pharmaceutical 20-day SMA is 60.55, which makes it a Sell.
-
Biomarin Pharmaceutical 50-day simple moving average is 63.45 while BMRN share price is 58.01, making it a Sell technically.
-
BMRN stock price is 58.01 and Biomarin Pharmaceutical 200-day simple moving average is 69.32, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Buy
56
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a BuyThe current Biomarin Pharmaceutical [BMRN] share price is $58.01. The Score for BMRN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
11.1B
Price in USD:
58.01
Share Volume:
2.4M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
94.85
52-Week Low:
52.93
Buy
56
Biomarin Pharmaceutical (BMRN)
is a Buy
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?The Biomarin Pharmaceutical stock price is 58.01 USD today.
-
Will BMRN stock go up or go down?Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Biomarin Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is not overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
-
Biomarin Pharmaceutical share price is 58.01 while BMRN 8-day exponential moving average is 59.07, which is a Sell signal.
-
The stock price of BMRN is 58.01 while Biomarin Pharmaceutical 20-day EMA is 60.08, which makes it a Sell.
-
Biomarin Pharmaceutical 50-day exponential moving average is 62.26 while BMRN share price is 58.01, making it a Sell technically.
-
BMRN stock price is 58.01 and Biomarin Pharmaceutical 200-day simple moving average is 68.85, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.25 per share, an increase this year of $1.01 per share, and an increase next year of $1.09 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
-
BMRN Moving Average Covergence Divergence (MACD) indicator is -1.17, suggesting Biomarin Pharmaceutical is a Sell
-
Biomarin Pharmaceutical Relative Strength Index (RSI) is 39.57, which suggest Biomarin Pharmaceutical is oversold
-
The Bollinger Bands (25) for Biomarin Pharmaceutical is (58.78 - 62.42), which suggest Biomarin Pharmaceutical is a Sell
-
The Bollinger Bands (100) for Biomarin Pharmaceutical is (60.17 - 69.27), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.